OPKO HEALTH, INC. Total Revenue

• OPKO HEALTH, INC. showed a decrease of -14.9% in Total Revenue from 2024 to 2025.
• This data is from OPKO HEALTH, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2017: $266.38 million | Q2 2017: $292.60 million | Q3 2017: $246.04 million | Q4 2017: $160.98 million | Q1 2018: $254.91 million | Q2 2018: $263.69 million | Q3 2018: $249.82 million | Q4 2018: $221.85 million | Q1 2019: $222.45 million | Q2 2019: $226.37 million | Q3 2019: $228.77 million | Q4 2019: $224.34 million | Q1 2020: $211.47 million | Q2 2020: $301.21 million | Q3 2020: $428.06 million | Q4 2020: $494.68 million | Q1 2021: $545.17 million | Q2 2021: $442.41 million | Q3 2021: $385.81 million | Q4 2021: $401.33 million | Q1 2022: $329.22 million | Q2 2022: $309.89 million | Q3 2022: $179.74 million | Q4 2022: $185.34 million | Q1 2023: $237.58 million | Q2 2023: $265.42 million | Q3 2023: $178.60 million | Q4 2023: $181.91 million | Q1 2024: $173.69 million | Q2 2024: $182.19 million | Q3 2024: $173.63 million | Q4 2024: $183.64 million | Q1 2025: $149.95 million | Q2 2025: $156.81 million | Q3 2025: $151.67 million | Q4 2025: $148.45 million.
• Over the full 10 years of available data (2016 to 2025), OPKO HEALTH, INC.'s Total Revenue has declined by 45.7%.
• Historical annual values: Fiscal year 2025: $606.88 million | Fiscal year 2024: $713.14 million | Fiscal year 2023: $863.50 million | Fiscal year 2022: $1.00 billion | Fiscal year 2021: $1.77 billion | Fiscal year 2020: $1.44 billion | Fiscal year 2019: $901.94 million | Fiscal year 2018: $990.27 million | Fiscal year 2017: $966.01 million | Fiscal year 2016: $1.12 billion.
• Data sourced from SEC EDGAR public filings as of August 4, 2026.

Last verified: August 4, 2026